The "golden hour" and acute brain ischemia: presenting features and lytic therapy in >30,000 patients arriving within 60 minutes of stroke onset.
about
Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart AssociationThe golden hour of acute ischemic stroke.Utilization of emergency medical service increases chance of thrombolytic therapy in patients with acute ischemic stroke.Efficacy and Safety of Cerebrolysin for Acute Ischemic Stroke: A Meta-Analysis of Randomized Controlled TrialsImaging-based treatment selection for intravenous and intra-arterial stroke therapies: a comprehensive review.Pharmacological and non-pharmacological recanalization strategies in acute ischemic stroke.Reducing door-to-puncture times for intra-arterial stroke therapy: a pilot quality improvement projectNeuropathic pain as a process: reversal of chronification in an animal model.Different expression patterns of Ngb and EPOR in the cerebral cortex and hippocampus revealed distinctive therapeutic effects of intranasal delivery of Neuro-EPO for ischemic insults to the gerbil brain.Prehospital paths and hospital arrival time of patients with acute coronary syndrome or stroke, a prospective observational study.Critical early thrombolytic and endovascular reperfusion therapy for acute ischemic stroke victims: a call for adjunct neuroprotection.The two pathophysiologies of focal brain ischemia: implications for translational stroke research.Patients living in impoverished areas have more severe ischemic strokes.Impact of Day of the Week and Time of Arrival on Ischemic Stroke Management.Cerebrolysin and Recovery After Stroke (CARS): A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial.Reducing door-to-needle times using Toyota's lean manufacturing principles and value stream analysis.The Effect of Emergency Medical Service Use and Inter-hospital Transfer on Prehospital Delay among Ischemic Stroke Patients: A Multicenter Observational StudyPrehospital Phase of the Stroke Chain of Survival: A Prospective Observational Study.Prehospital use of magnesium sulfate as neuroprotection in acute stroke.Predictors of diagnostic neuroimaging delays among adults presenting with symptoms suggestive of acute stroke in Ontario: a prospective cohort studyFast neuroprotection (fast-NPRX) for acute ischemic stroke victims: the time for treatment is now.Lettuce glycoside B ameliorates cerebral ischemia reperfusion injury by increasing nerve growth factor and neurotrophin-3 expression of cerebral cortex in rats.Meta-analysis of preclinical studies of mesenchymal stromal cells for ischemic stroke.Prenotification and other factors involved in rapid tPA administration.Minimising time to treatment: targeted strategies to minimise time to thrombolysis for acute ischaemic stroke.Stroke service: how can we improve and measure outcomes? Consensus summary from a global stroke forum.Future directions for intra-arterial therapy for acute ischaemic stroke: is there life after three negative randomized controlled studies?The erythropoietin-derived peptide MK-X and erythropoietin have neuroprotective effects against ischemic brain damage.Ambulance-delivered transdermal glyceryl trinitrate versus sham for ultra-acute stroke: Rationale, design and protocol for the Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial-2 (RIGHT-2) trial (ISRCTN26986053).The High Cost of Stroke and Stroke Cytoprotection Research.Timely Reperfusion in Stroke and Myocardial Infarction Is Not Correlated: An Opportunity for Better Coordination of Acute Care.Factors that influence clinicians' decisions to offer intravenous alteplase in acute ischemic stroke patients with uncertain treatment indication: Results of a discrete choice experiment.Intravenous thrombolysis for acute stroke: current standards and future directions.The American Heart Association's Get With the Guidelines (GWTG)-Stroke development and impact on stroke care.Perfluorocarbons enhance a T2*-based MRI technique for identifying the penumbra in a rat model of acute ischemic stroke.Positive impact of the participation in the ENCHANTED trial in reducing Door-to-Needle Time.Reasons for low thrombolysis rate in a Norwegian ischemic stroke population.Organizational changes aiming to reduce iv tPA door-to-needle time.Fast-track intubation for accelerated interventional stroke treatment.If Time Is Brain Where Is the Improvement in Prehospital Time after Stroke?
P2860
Q30238784-2F5FBB18-15B8-43B5-A0A3-418EF6FCC5DFQ33716599-2C52D55F-1EC3-4B51-BAC6-C451427DF3E6Q33801117-BC5C122A-92A5-4C5D-8B8A-3F3DF48F72D8Q33809873-CA0B0B32-88F7-45C0-8C14-F5CCDF4387F2Q33978760-D0A81B39-BB49-4254-9D89-C4CC7876854DQ35017281-E7F3E7B0-87D3-4817-9502-61DF13981154Q35114843-7FF1EB02-FABB-443F-A40F-C226087E0635Q35328143-D34762BF-0D79-459E-B2AF-9FD0CD6ED823Q35440761-9DD51624-4A21-48FF-8EDB-188AE24D4D43Q35889459-F8F7841D-6199-471A-81BD-091F78D5CBD8Q36056147-4B4DD00F-4150-4B92-A3BC-48A0308B7CDCQ36079309-BAE3F4C2-0B8F-46F1-9A59-45235482EB7DQ36205572-64173EC7-E489-4918-8E3C-13E99B5B4F70Q36249194-3297B3E0-BD6A-4D1F-B465-79E2DB893EA5Q36398799-D95DCDB1-0CF5-464E-86D8-DC49E6AD0BC5Q36428769-EE089D4A-F119-4023-AE82-62865860C5F5Q36461538-4ECBE26B-C12B-40EF-A16D-D96BA90AF674Q36956672-6D30F42A-A29D-496A-BAE1-B8F21CF08A85Q37036998-52FF841D-ED20-4F0C-A541-E7709313237CQ37066883-911CEFEE-1575-4245-A213-86EAA5459C2AQ37420266-033C8499-9000-4DC4-B06E-F9BB635FA363Q37551521-D3BBAFCB-3248-4FC4-B115-7D7B179773FAQ37725913-7DE5D385-71FD-43AB-997B-09C3FD6C3B9DQ38108225-2C6DBE01-EEA3-480F-9364-7BBFCDA4F721Q38111820-61C41B62-FCB6-4957-8231-BF3CA9E22F74Q38209361-3278AFA9-2C02-43CC-A329-FCBFCAEFD447Q38246014-472307BF-7CA0-4844-8E8E-5C7C4A7CA98AQ38399783-CECD60F9-2D1F-4E4A-A15F-7A0D1A9B7B01Q38649591-D90F9587-F702-4479-A406-0DC5E173E943Q38776049-4EE2D2F3-D866-4F75-BC99-5DA2614EA52BQ38914102-29992560-A25C-49C0-ACCB-2A97A54EC79EQ38992591-E702FDE6-4C34-4837-BEC3-0B3EB2C3B041Q39028528-CFCA9F06-989D-4821-B109-5E5D564B0C85Q41678497-1E3FA098-EE85-4784-AAD4-A42EF8D04F3BQ42586972-AEE8C4DF-2545-496A-A399-C16A4F17A637Q42620671-C90DEA90-459A-41E3-8659-5AB18620D48AQ42672339-CA97BD24-9CEC-4CBF-B813-D0CB5D77FE96Q44636590-4421998D-A8C0-4C18-8B58-C878D04B8454Q44707981-A349C28C-3124-44D6-BC7A-C99E4E0C00B3Q47098542-E3FEBF85-02B4-42E0-8207-AD761439521F
P2860
The "golden hour" and acute brain ischemia: presenting features and lytic therapy in >30,000 patients arriving within 60 minutes of stroke onset.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The "golden hour" and acute br ...... in 60 minutes of stroke onset.
@ast
The "golden hour" and acute br ...... in 60 minutes of stroke onset.
@en
The "golden hour" and acute br ...... in 60 minutes of stroke onset.
@nl
type
label
The "golden hour" and acute br ...... in 60 minutes of stroke onset.
@ast
The "golden hour" and acute br ...... in 60 minutes of stroke onset.
@en
The "golden hour" and acute br ...... in 60 minutes of stroke onset.
@nl
prefLabel
The "golden hour" and acute br ...... in 60 minutes of stroke onset.
@ast
The "golden hour" and acute br ...... in 60 minutes of stroke onset.
@en
The "golden hour" and acute br ...... in 60 minutes of stroke onset.
@nl
P2093
P2860
P50
P1433
P1476
The "golden hour" and acute br ...... hin 60 minutes of stroke onset
@en
P2093
GWTG-Stroke Steering Committee and Investigators
Mathew J Reeves
P2860
P304
P356
10.1161/STROKEAHA.110.583815
P407
P577
2010-06-03T00:00:00Z